| Autor: |
Petäjä LM; Department of Anesthesiology and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. liisa.petaja@hus.fi, Sipponen JT, Hämmäinen PJ, Eriksson HI, Salmenperä MT, Suojaranta-Ylinen RT |
| Jazyk: |
angličtina |
| Zdroj: |
The Annals of thoracic surgery [Ann Thorac Surg] 2006 Oct; Vol. 82 (4), pp. 1529-31. |
| DOI: |
10.1016/j.athoracsur.2006.02.026 |
| Abstrakt: |
After heart transplantation primary graft failure is a major cause of early mortality. Treatment options include inotropes and mechanical assist devices. Developing better methods would impact on patients' short- and long-term survival. We present a case of primary graft failure manifested as cardiogenic shock unresponsive to catecholamines and a phosphodiesterase inhibitor. Reversal of low output syndrome was achieved with a new type of inotropic agent, levosimendan, leading to the later complete recovery. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
